Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy.

allodynia cisplatin milnacipran neuropathy pain

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
27 Aug 2023
Historique:
received: 18 07 2023
revised: 20 08 2023
accepted: 22 08 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

(1) Background: Milnacipran is a typical serotonin-norepinephrine reuptake inhibitor and has been shown to have analgesic effects in several pain models. However, its antihyperalgesic effect in cisplatin-induced neuropathy remains unknown. We examined the effects of intraperitoneal (IP) milnacipran on allodynia in cisplatin-induced peripheral neuropathic mice. (2) Methods: Peripheral neuropathy was induced by injecting cisplatin (2.3 mg/kg/day, IP) six times, on every other day. Saline or milnacipran (10, 30, 50 mg/kg, IP) were then administered to the neuropathic mice. We examined mechanical allodynia using von Frey hairs at preadministration and at 30, 60, 90, 120, 180, 240 min and 24 h after drug administration. We also measured the dorsal root ganglion (DRG) activating transcription factor 3 (ATF3) to confirm the analgesic effects of milnacipran. (3) Results: For the milnacipran groups, the decreased paw withdrawal thresholds to mechanical stimuli were significantly reversed when compared to the preadministration values and the values in the saline-injected control group (

Identifiants

pubmed: 37765187
pii: pharmaceutics15092218
doi: 10.3390/pharmaceutics15092218
pmc: PMC10535450
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Pharmacol Res. 2021 Dec;174:105921
pubmed: 34601079
J Biol Chem. 1996 Jan 19;271(3):1695-701
pubmed: 8576171
Clin Neuropharmacol. 2009 Nov-Dec;32(6):355-63
pubmed: 19620845
Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:49-56
pubmed: 25619459
Anesth Analg. 2013 Jan;116(1):224-31
pubmed: 23223118
Korean J Anesthesiol. 2014 Jul;67(1):4-7
pubmed: 25097731
Korean J Pain. 2021 Jan 01;34(1):27-34
pubmed: 33380565
ISRN Pain. 2014 Feb 23;2014:915464
pubmed: 27335884
Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:15-27
pubmed: 8923123
Cancer Med. 2022 Jul;11(14):2801-2816
pubmed: 35322580
Pain. 2014 Dec;155(12):2461-2470
pubmed: 25261162
Pain. 2007 Apr;128(3):272-282
pubmed: 17276007
Clin Cancer Res. 2017 Oct 1;23(19):5757-5768
pubmed: 28611204
Ann Oncol. 2017 Nov 01;28(11):2670-2679
pubmed: 29045502
Drugs Today (Barc). 1998 Aug;34(8):709-20
pubmed: 14988777
J Clin Oncol. 2014 Oct 1;32(28):3085-92
pubmed: 25024068
Biomed Res. 2013 Apr;34(2):105-11
pubmed: 23594484
Pain Physician. 2017 May;20(4):E593-E600
pubmed: 28535568
Health Psychol Res. 2021 Jul 10;9(1):25532
pubmed: 34746490
Neurosci Res. 2009 Jan;63(1):42-6
pubmed: 18992286
J Korean Med Sci. 2012 Nov;27(11):1411-7
pubmed: 23166426
Biol Pharm Bull. 2015;38(1):151-4
pubmed: 25744472
Anesth Analg. 2002 Jul;95(1):163-8, table of contents
pubmed: 12088962
J Pharmacol Exp Ther. 2004 Nov;311(2):576-84
pubmed: 15254142
Pain Physician. 2018 Nov;21(6):571-592
pubmed: 30508986
J Neurosci Methods. 1994 Jul;53(1):55-63
pubmed: 7990513
Int J Mol Sci. 2017 Nov 21;18(11):
pubmed: 29160850
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Neurogastroenterol Motil. 2013 May;25(5):373-82, e292
pubmed: 23594243
Br J Haematol. 2009 Apr;145(1):3-14
pubmed: 19170681
Nat Rev Neurosci. 2001 Feb;2(2):83-91
pubmed: 11252998
Cancer Chemother Pharmacol. 2014 Jan;73(1):25-34
pubmed: 24162377
Korean J Pain. 2021 Oct 01;34(4):427-436
pubmed: 34593660
J Neurosci. 2012 May 16;32(20):7091-101
pubmed: 22593077
Biomed Pharmacother. 2023 Jan;157:114045
pubmed: 36455457
J Neurochem. 1997 Aug;69(2):815-22
pubmed: 9231743
Korean J Anesthesiol. 2020 Oct;73(5):434-444
pubmed: 32046474
Support Care Cancer. 2012 Mar;20(3):625-32
pubmed: 21479990
Asia Pac J Oncol Nurs. 2016 Jan-Mar;3(1):73-85
pubmed: 27981142
Anesth Analg. 2008 Apr;106(4):1309-15, table of contents
pubmed: 18349211
JAMA. 2013 Apr 3;309(13):1359-67
pubmed: 23549581
Support Care Cancer. 2021 Feb;29(2):833-840
pubmed: 32500206
Immunol Res. 2022 Dec;70(6):725-741
pubmed: 35859244
Neurosci Lett. 2015 Jun 2;596:90-107
pubmed: 25459280
Front Pain Res (Lausanne). 2021 Dec 24;2:740897
pubmed: 35295451
Cancer Treat Rev. 2007 Feb;33(1):9-23
pubmed: 17084534

Auteurs

Sun Jin Cho (SJ)

Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Jin Young Lee (JY)

Department of Anesthesiology and Pain Medicine, Samsung Medical Center, College of Medicine, The Sungkyunkwan University of Korea, Seoul 06351, Republic of Korea.

Yujin Jeong (Y)

Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

So Yeon Cho (SY)

Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Do-Gyeong Lee (DG)

Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Ji Yeon Choi (JY)

Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Hue Jung Park (HJ)

Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Classifications MeSH